Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
GenWay Biotech Announces Changes to Board of Directors
GenWay Biotech, a leading provider of protein and antibody solutions, today announced the appointment of Thomas Silberg, President and Chief Executive Officer of GenWay Biotech as Chairman of the Board, and Joseph Panetta, President and Chief Executive Officer (CEO) of BIOCOM and Robert Richard Garber, PhD, Drug Development Consultant as members of the Board of Directors. - November 14, 2013 - GenWay Biotech
SFL’s Managing Director to Give Presentation at Informa’s 8th Annual Drug Device Combination Products Event in Berlin
SFL’s Managing Director provides regulatory insight into Drug Device Combination Products in Europe. - November 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Creative Biomart Announces Commercial Agreement for Services of Biosimilar Cell Lines Manufacturing
Creative Biomart announced today that it has signed a commercial agreement for contract manufacturing pharmaceutical biosimilar cell lines for a big pharma company. - November 10, 2013 - Creative Biomart
Chinese Pharma Performance Slows Further in 2013 Amid Government Crackdowns
The overall trend of Chinese pharma this year shows continued decline of profitability despite sustained relatively high output value and revenue growth. Both hospital drug sales and pharmaceutical retail sales growth are slowing, while western medicine foreign trade remained to grow at a low rate, according to China Pharmaceutical Guide 2013 (8th Edition) from WiCON International Group LLC, the publisher of Pharma China. - November 08, 2013 - WiCON International Group LLC
ViGene Biosciences Introduces World’s Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
ViGene Biosciences Product Launch- Introducing premade miRNA and cDNA adenoviruses. - November 08, 2013 - ViGene Biosciences
Creative Biolabs Launches New Service—Membrane Protein Production
Creative Biolabs expands its service lines to membrane protein production based on its unique MemProTM technique. - November 08, 2013 - Creative Biolabs
VIRUN® & Vital Pharmaceuticals® Expand Operations to Offer a Combined 29 Patents for Raw Material Manufacturing and Finished Product Capabilities
The year 2013 has been a blockbuster renaissance of key partnerships and explosive innovation for VIRUN; early in the year, VIRUN published Chapter 39, Nanotechnology and Nonpolar Active Compounds in Functional Foods through Wiley. In March, Stepan Lipid Nutrition and VIRUN formalized a partnership... - November 05, 2013 - VIRUN
epDualfilter TIPS® and Pipette.com’s Tips for Rainin LTS® Pipettes Now Available at Pipette.com
Pipette.com, liquid handling experts for over 17 years, announces an expansion of their tip offering with epDualfilter TIPS® as well as Pipette.com’s alternative tips for Rainin LTS® tips. The expansion will benefit labs looking to get more accurate and precise lab results. - November 02, 2013 - Pipette.com
AnaSpec Introduces SensoLyte® 520 TEV (Tobacco Etch Virus) Protease Assay Kit
SensoLyte® 520 TEV (Tobacco Etch Virus) Protease Assay Kit is used for measuring TEV protease quantity and activity. TEV protease is widely used to remove fusion tags from recombinant proteins. - November 01, 2013 - AnaSpec, EGT Group
AveXis-BioLife Launch New Website
AveXis-BioLife is pleased to announce the launch of the company’s brand new website: www.avexisinc.com. The October 2013 unveiling of the website coincides with the company’s licensing of the gene therapy program from The Kaspar Laboratory for the treatment of Spinal Muscular Atrophy... - November 01, 2013 - AveXis Inc.
ALPCO Expands Product Offering with Addition of Mouse-Specific Flow Cytometry Reagents
Earlier this year, ALPCO began offering flow cytometry reagents and data analysis software. As promised, the company has recently added high quality and affordable mouse reagents to their growing flow cytometry portfolio. Among the 600 new mouse reagents are antibodies for CD3, CD4, CD8 and... - October 29, 2013 - ALPCO
Kingfisher Biotech Expands Its Portfolio of Mouse Proteins with 3 New Proteins
Mouse CCL4, CXCL9, and CXCL10 are important members of the chemokine family of proteins. The major role of chemokines is to act as a chemoattractant to guide the migration of cells. CCL4 (MIP-1 beta) attracts monocytes and macrophages primarily. CXCL9 (MIG) and CXCL10 (IP-10) are known to recruit... - October 25, 2013 - Kingfisher Biotech
Geoffrey H. Saft, Owner of California Hyperbaric Equipment Company, Celebrating 8-Years of Hyperbaric Oxygen Equipment Sales
Geoffrey H. Saft, owner of California Hyperbaric Equipment Company, has announced he is now celebrating 8 years of providing clients with the highest quality of service for hyperbaric oxygen chambers and accessories. He is certified in hyperbaric therapy and his training and years of experience... - October 24, 2013 - Hyperbaric Oxygen CA
AveXis-BioLife Licenses Spinal Muscular Atrophy (SMA) Patent Portfolio from Nationwide Children's Hospital and The Ohio State University
BioLife, a synthetic biology platform company soon to be renamed AveXis, has been granted exclusive rights to the spinal muscular atrophy gene therapy program developed at The Research Institute at Nationwide Children’s Hospital and The Ohio State University in Columbus, Ohio. The license... - October 21, 2013 - AveXis Inc.
Creative Biomart Releases New Products in the Middle of Oct.
In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart
Peter Openshaw, Director at CRI, to Speak at Innate Immunity Meeting, Jan 29-31, 2014, San Diego, CA
Peter Openshaw, Director at the National Heart and Lung Institute will give a presentation at the Inaugural Innate Immunity Conference, January 29-31, 2014 in San Diego, CA. - October 19, 2013 - GTCbio
Microfluidics Startup NanoCellect Adds Strategic Advisors and Nabs Another $700K from the NIH
NanoCellect, (previously called NanoSort) aims to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more affordable and easier to use. Spunout from UCSD in late 2009, NanoCellect has now raised over $3.3M including a new $700K grant to continue developing... - October 19, 2013 - NanoCellect
AveXis BioLife Announce The Research Institute at Nationwide Children’s Hospital Received Fast Track Status for Spinal Muscular Atrophy Treatment
AveXis and BioLife, synthetic biology platform companies, today announced that The Research Institute at Nationwide Children’s Hospital received Fast Track designation from the U.S. Food and Drug Administration for its scAAV9.CB.SMN gene therapy product for the treatment of spinal muscular... - October 18, 2013 - AveXis Inc.
VStock Transfer Congratulates Its Client, Soft Landing Labs, LTD., on Securing DTC Eligibility
Soft Landing Labs, LTD. obtains DTC Eligibility. - October 16, 2013 - Vstock Transfer, LLC
Epitope Diagnostics Launches the Second Generation Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate (ADC) Levels
Epitope Diagnostics has recently launched second-generation ADC kits exclusively for the quantitative measurement of DM1-, MMAE-, and MMAF-ADC level. These kits measure both humanized monoclonal antibody based ADC and mouse monoclonal antibody based ADC. Additional benefits for testing PK samples from mice are utilized by these second generation kits. - October 12, 2013 - Epitope Diagnostics, Inc.
Gonzalo Goicochea, Recently Recognized by America's Registry of Outstanding Professionals
America's Registry of Outstanding Professionals recognized Gonzalo Goicochea of Miami, Florida for his accomplishments in the field of Biometrics. Based on his achievements, he has been selected as Professional of the Year 2013. About Gonzalo Goicochea Gonzalo Goicochea was born in West Palm... - October 11, 2013 - America's Registry of Outstanding Professionals
AsisChem Launches New Streamlined Website with Improved Product Search and E-Commerce Features
AsisChem, the contract medicinal drug and drug discovery and research company co-located in Waltham, Massachusetts and St. Petersburg Russia, announced today the launch of its new website with searchable product profiles and e-commerce shopping functions. The new design of www.asischem.com greatly... - October 08, 2013 - AsisChem
Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference
Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013 - Rosa & Co LLC
Xavier Jacq, of Mission to Speak at 4th Ubiquitin Conference, Feb 20-21, 2014, San Diego, CA
Xavier Jacq, Co-founder and Head of Biology and Screening Activities at Mission Therapeutics, to Give a Presentation at the 4th Ubiquitin Research and Drug Discovery 2014, February 20-21, 2014 in San Diego, CA - October 05, 2013 - GTCbio
Biotech Consultancy Firm Moves Headquarters to Marlborough
Boston Biomedical Associates announces relocation at MassBio Regional Mixer. - October 05, 2013 - Marlborough Economic Development Corporation
Captiva Spine’s Proprietary PivoRod® Articulating Minimally Invasive Spinal Rod Receives New U.S. Patent Allowance From US Patent Office
Captiva Spine, Inc., a medical device organization dedicated to developing and distributing spinal technologies in the US and internationally, announced today that a new U.S. patent has been allowed by the USPTO for Captiva Spine’s Proprietary PivoRod® Articulating Minimally Invasive... - October 03, 2013 - Captiva Spine, Inc
MD Stem Cells Indicates Government Shutdown Will Not Impact SCOTS Eye Stem Cell Treatment Study
MD Stem Cells sees no immediate effect on the SCOTS eye stem cell trial but is monitoring NIH throughout the government shutdown. - October 03, 2013 - MD Stem Cells
Market Insight: Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Frost & Sullivan
New market insight uncovers the latest technology trends and strategic approaches for biopharma CMOs. - October 03, 2013 - Frost & Sullivan
New 2-Way & 3-Way Inert Isolation Valve Ideal for Automated Chemistry Applications
RVA Series Manifold Mount Valves feature small footprint, reduced energy consumption, and low heat generation. Can be used in continuous duty applications. - October 02, 2013 - Clark Solutions
Haruki Hasegawa Speaks on Russell Body Phenotype at Protein Expression Conf., Oct. 24-25, San Diego
Haruki Hasegawa, Principal Scientist of Therapeutic Discovery at Amgen to Speak on Russell Body Phenotype at GTC’s Protein Expression, Purification & Characterization Conference on October 24–25, 2013 in San Diego, CA - October 01, 2013 - GTCbio
Michael Naso, Janssen, to Present at Antibody & Protein Therapeutics Mtg., Oct. 24-25, San Diego
Michael Naso, Associate Director at Janssen R&D, Will Give a Presentation Titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities” at GTC’s Antibody & Protein Therapeutics Conference on October 24–25, 2013 in San Diego, CA - October 01, 2013 - GTCbio
Science Celebrity Geoff Notkin Kicks Off Fall Season with New TV Show
It doesn’t feel like autumn in much of Arizona, but the unrelenting heat hasn’t deterred intrepid TV host and adventurer Geoff Notkin from filming his exciting new TV series, STEM Journals at locations throughout the state. Set to debut its second season on Sunday, October 20 on Cox 7... - September 25, 2013 - Aerolite Meteorites, LLC
Emerge Diagnostics Receives FDA 510(k) Clearance for Wireless Device
Emerge Diagnostics is pleased to announce that it has received the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wireless device, PMRU-S. The new clearance will allow for expansion of the EFA technology. The wireless ability will streamline the assessment process as... - September 23, 2013 - Emerge Diagnostics
Creative Biolabs Designs Novel Techniques to Solve Problems Met in Dimerization of ScFv/Fab
In designing strategies for dimerization of antibody fragments, Creative Biolabs has developed novel techniques to solve tricky issues, such as stability and homogeneity of the dimers, resistance to proteolytic cleavage during in vivo assembly, efficient production of preferably soluble protein,... - September 22, 2013 - Creative Biolabs
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart
Jules Hoffmann to Give Plenary Keynote at Immunotherapeutics Summit Jan 29-31, 2014 in San Diego, CA
Jules Hoffmann, Nobel Laureate and Invited Professor at Strasbourg University to Give Plenary Keynote Address at Novel Immunotherapeutics Summit on January 29-31, 2014 in San Diego, CA. - September 20, 2013 - GTCbio
Pamela Ronald, UC Davis to Speak at Innate Immunity Conference, Jan 29-31, 2014, San Diego, CA
Pamela Ronald, Professor and Director of the Laboratory for Crop Genetics Innovation and Scientific Literacy from the University of California, Davis, to Give a Featured Presentation at the Inaugural Innate Immunity Conference 2014, January 29-31, 2014 in San Diego, CA. - September 20, 2013 - GTCbio
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
NIH Awards Advaita $2.0M for Disease Subtyping and Drug Repurposing Technology Development
The National Institute of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita Bioinformatics, of Plymouth, Michigan to develop biological... - September 13, 2013 - Advaita
International Polymer Solutions Launches New Website
TEQCOM and BECO websites merge to form new International Polymer Solutions site. - September 12, 2013 - International Polymer Solutions Inc.
Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)
Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics
Robert Petrovich, NIEH, to Speak at GTC’s Protein Expression Conf., Oct. 24-25, San Diego
Robert Petrovich, Leader of the Protein Expression Core Facility of the Laboratory of Structural Biology at the National Institute of Environmental Health Sciences to Speak on “Expression and Purification of Proteins in a Budget Limited World” at GTC’s Protein Expression, Purification & Characterization Conference on October 24–25, 2013 in San Diego, CA - September 10, 2013 - GTCbio
Meditech Global, Inc. to Attend the 9th World Meeting on Pharmaceutics, Bio-Pharmaceutics and Pharmaceutical Technology
Meditech Global, Inc., a healthcare and Life Science venture capital company, is pleased to announce they will be attending the 9th World Meeting on Pharmaceutics, Bio-pharmaceutics and Pharmaceutical Technology. - September 10, 2013 - Meditech Global Inc
Creative Biolabs Launches "One-Stop" Phage Display Services
After services expansion, Creative Biolabs is delighted to announce the launch of “one-stop” phage display services for researchers and institutions. - September 08, 2013 - Creative Biolabs
Creative Biolabs Works with UEC for Commercial Phage Display Technology
Creative Biolabs works with UEC for a bioscience and technology program. During the time, Creative Biolabs offers custom phage display construction and screening services by signing a custom service contract for commercial pre-made library. - August 30, 2013 - Creative Biolabs
Creative Biolabs Establishes Solid Platform for DNA Sequencing of Monoclonal Antibodies
Creative BioLabs has established a solid platform for DNA sequencing of both IgG and IgM types of monoclonal antibodies produced by mouse and rat hybridoma cell lines. - August 29, 2013 - Creative Biolabs
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart
BIOCAD Company and KOÇAK FARMA Sign a Definitive Agreement on Rituximab
A Definitive Agreement on export of rituximab API produced by CJSC BIOCAD to Turkey was signed on August 13th, 2013 between CJSC BIOCAD and KOÇAK FARMA, a leading Turkish pharmaceutical company with strong presence in the area of oncology. - August 24, 2013 - biocad
Zenalux Research Partnership with Roswell Park Cancer Institute Deploys Zenascope™ PC1 in Interstitial Photodynamic Therapy
Zenalux Biomedical, Inc., a biomedical diagnostics company, is now collaborating with Roswell Park Cancer Institute through the Zenalux Research Partnership program. The partnership has been formed to enable Roswell to use the Zenascope™ PC1 for interstitial photodynamic therapy. The PC1 will... - August 22, 2013 - Zenalux Biomedical, Inc.
International Medical Ventures, Inc. to Attend The 2nd International Conference on Genomics in the Americas
International Medical Ventures, Inc., an early stage life science venture capital company, is pleased to announce they will be attending The 2nd International Conference on Genomics in the Americas. The show is put on by BGI, the largest genomics center in the world and will take place on 12 and 13... - August 21, 2013 - International Medical Ventures Inc